Fine Organic's Q2FY24 Financial Performance Review

In this financial performance review, we delve into the results of Fine Organics for the second quarter of fiscal year 2024 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23YoY (% change)Q1FY24QoQ (% change)Q2FY24
Total Income (₹crs.)938.51-40.58516.627.94557.64
Expenses (₹crs.)678.04-37.38418.321.49424.56
Net Profit (₹crs.)202.62-48.9999.763.61103.36
Margin (%)21.59-3.0519.31-0.7718.54

 

REVENUE: 
Fine Organics reported a total revenue of ₹557.64 crores for Q2FY24. This represents a significant increase of 7.94% sequentially. However, year-on-year, the company experienced a substantial decline of -40.58%.

 

EXPENSES: 
The company recorded expenses amounting to ₹424.56 crores in Q2FY24, reflecting a minor 1.49% seqeuntially. Year-on-year, expenses have decreased by -37.38% compared to ₹678.04 crores.

 

NET PROFIT: 
In the second quarter of fiscal year 2024, Fine Organics reported a net profit of ₹103.36 crores, demonstrating a modest 3.61% to Q1FY24. Nevertheless, the net profit has seen a considerable decline of -48.99% compared to the net profit in Q2FY23.

 

MARGINS: 
The margin for Q2FY24 is 18.54%, reflecting a marginal decrease of -0.77% compared to  Q1FY24. Year-on-year, the margin has declined by -3.05% from 21.59% in Q2FY23.

 

In conclusion, Fine Organics' financial performance in the second quarter of fiscal year 2024 shows a mixed picture. While the company managed to increase its revenue compared to the previous quarter, the year-on-year revenue decline remains significant. 

 

The marginal increase in net profit is promising but may require further growth to offset the substantial YoY decline. Expense management has improved compared to the previous year. 

 

Stay tuned for more updates on upcoming financial performances.

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Share Market

blog-logo

9 mins read . 11 Oct 2024

Public Sector Undertakings in India

  • 0 people read
blog-logo

Share Market

blog-logo

7 mins read . 11 Oct 2024

How Did Rakesh Jhunjhunwala Become a Billionaire?

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions